SCHEMBL4909535

SCHEMBL4909535

COC(=O)c1cc(S(=O)(=O)NCCOc2ccc(OCc3ccccc3)cc2)ccc1C

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.57
NPSR1 Q6W5P4 1/20 0.54
ALDH1A1 P00352 2/20 0.53
KMT2A Q03164 6/20 0.52
MEN1 O00255 5/20 0.52
HTT P42858 1/20 0.52
MMP9 P14780 2/20 0.51
MMP13 P45452 2/20 0.51
ADAM17 P78536 2/20 0.51
ADAMTS4 O75173 1/20 0.51
MMP1 P03956 1/20 0.51
MMP2 P08253 1/20 0.51
MMP14 P50281 1/20 0.51
ADAMTS5 Q9UNA0 1/20 0.51
PKM P14618 1/20 0.50
LMNA P02545 2/20 0.49
RAB9A P51151 1/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2C9 P11712 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4895501 0.93 LMNA (0.58) TDP1NPSR1ALDH1A1KMT2AMEN1
SCHEMBL4905124 0.91 ALDH1A1 (0.55) ALDH1A1KMT2AMEN1HTTMMP9
SCHEMBL4906713 0.89 TDP1 (0.59) TDP1NPSR1ALDH1A1KMT2AMEN1
SCHEMBL6530253 0.86 LNPEP (0.47) TDP1NPSR1KMT2AMEN1MMP9
SCHEMBL5373265 0.84 KMT2A (0.64) TDP1KMT2AMEN1PKMAR
SCHEMBL4902960 0.83 ALDH1A1 (0.53) ALDH1A1KMT2AMEN1HTTPKM
SCHEMBL4905979 0.83 LMNA (0.57) ALDH1A1KMT2AMEN1HTTMMP9
SCHEMBL4902606 0.83 TDP1 (0.51) TDP1NPSR1ALDH1A1KMT2AMEN1
SCHEMBL4899834 0.82 LMNA (0.60) TDP1NPSR1ALDH1A1KMT2AMEN1
SCHEMBL4895764 0.82 MAPT (0.54) NPSR1ALDH1A1KMT2AMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD TDP1 3363/4885NPSR1 773/4885ALDH1A1 2664/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD TDP1 3653/4885NPSR1 735/4885ALDH1A1 2956/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.